Biorem Inc Stock Today
| BRM Stock | CAD 2.85 0.02 0.70% |
Performance4 of 100
| Odds Of DistressLess than 2
|
BioRem is selling for under 2.85 as of the 17th of January 2025; that is 0.7% down since the beginning of the trading day. The stock's lowest day price was 2.85. BioRem has a very small chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. The performance scores are derived for the period starting the 28th of January 2023 and ending today, the 17th of January 2025. Click here to learn more.
Business Domain Capital Goods | Category Industrials |
BIOREM Inc., an environmental biotechnology company, designs, manufactures, and sells air emissions control systems that are used to eliminate odors, volatile organic compounds , and hazardous air pollutants in Canada, the United States, China, and internationally. The company has 15.8 M outstanding shares of which 2.67 K shares are currently shorted by private and institutional investors with about 0.21 days to cover all short positions. More on BioRem Inc
Moving together with BioRem Stock
Moving against BioRem Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
BioRem Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BioRem's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BioRem or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President CEO | PEng MBA | ||||
| Business Concentration | Industrial Machinery & Supplies & Components, Pollution & Treatment Controls, Industrials, Industrials, Machinery, Pollution & Treatment Controls, Industrials (View all Sectors) | ||||
BioRem's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to BioRem's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsBioRem can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand BioRem's financial leverage. It provides some insight into what part of BioRem's total assets is financed by creditors.
| |||||
BioRem Inc (BRM) is traded on TSX Venture Exchange in Canada and employs 4 people. BioRem is listed under Industrial Machinery & Supplies & Components category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 46.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioRem's market, we take the total number of its shares issued and multiply it by BioRem's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioRem Inc classifies itself under Machinery sector and is part of Industrials industry. The entity has 15.8 M outstanding shares of which 2.67 K shares are currently shorted by private and institutional investors with about 0.21 days to cover all short positions.
BioRem Inc has accumulated about 5.75 M in cash with 490.03 K of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16.
Check BioRem Probability Of Bankruptcy
Ownership AllocationBioRem holds a total of 15.8 Million outstanding shares. Almost 97.67 percent of BioRem outstanding shares are held by general public with 1.9 (percent) owned by insiders and only 0.44 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BioRem Ownership Details
BioRem Inc Risk Profiles
Although BioRem's alpha and beta are two of the key measurements used to evaluate BioRem's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.01 | |||
| Semi Deviation | 3.17 | |||
| Standard Deviation | 3.9 | |||
| Variance | 15.22 |
BioRem Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioRem without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
BioRem Corporate Executives
Elected by the shareholders, the BioRem's board of directors comprises two types of representatives: BioRem inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioRem. The board's role is to monitor BioRem's management team and ensure that shareholders' interests are well served. BioRem's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioRem's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Douglas Newman | CFO, Secretary | Profile |
Additional Tools for BioRem Stock Analysis
When running BioRem's price analysis, check to measure BioRem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioRem is operating at the current time. Most of BioRem's value examination focuses on studying past and present price action to predict the probability of BioRem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioRem's price. Additionally, you may evaluate how the addition of BioRem to your portfolios can decrease your overall portfolio volatility.